MHRA为MedSafetyWeek启动患者安全征文比赛
正文 · 中文译文
新闻稿 MHRA为MedSafetyWeek启动患者安全征文比赛 MHRA提醒患者、家长、照护者和医疗保健专业人员，在2026年MedSafetyWeek期间通过黄卡计划报告疑似不良反应。 来源： 药品和医疗保健产品监管局 发布时间： 2026年11月2日 #MedSafetyWeek宣传图 药品和医疗保健产品监管局（MHRA）敦促所有人帮助保护患者，作为第十一届年度#MedSafetyWeek活动（2026年11月2日至8日）的一部分，通过黄卡计划报告药品和医疗保健产品（包括医疗器械）的所有类型安全问题。 今年的全球活动信息明确：“不要忽视疑似不良反应，请报告它们。”来自120多个国家的130多个组织将用60多种语言传播药品安全信息。 您可以通过使用黄卡网站上的新活动材料来支持该活动，提高对黄卡计划的认识，包括海报、数字屏幕、候诊室材料和社交媒体素材，以提高认识并促进黄卡报告，并通过关注MHRA社交媒体渠道并使用#MHRAYellowCard、#MedSafetyWeek、#ReportSideEffects和#patientsafety分享内容来提高报告意识。 为配合#MedSafetyWeek（药物安全周），MHRA（英国药品和保健品管理局）还启动了2026年全国患者安全征文比赛，主题为人工智能（AI）相关不良事件的发现与报告。今年比赛还邀请药学专业学生与英国医学生同台参赛。 在强烈需求下，征文比赛向药学专业学生开放 MHRA患者安全征文比赛于去年启动，反响热烈，共收到来自英国30多所医学院校的68篇投稿。在药剂师表达参与意愿的询问之后，MHRA已将2026年比赛扩展至药学专业学生，以体现药学专业人员在药物安全中发挥的重要作用。 参赛者须提交一篇不超过2，000字的文章，主题为：“人工智能（AI）预计将在未来5年内于医疗保健领域发挥变革性作用。请举例说明Yellow Card计划如何能够识别与将AI作为医疗器械采用相关的风险。请思考患者和医疗保健专业人员利用Yellow Card计划改进AI相关不良事件发现与报告的实际方法。请讨论改进报告如何能够支持AI赋能医疗器械的安全使用。” 截止日期为2027年1月11日（星期一）。共设六个奖项。一等奖获得者将获得500英镑奖金，并受邀在人类药物委员会（CHM）——药物安全独立咨询机构——及临时器械工作组（IDWG）的全国会议上展示其论文。每个类别还设有二等奖300英镑和三等奖200英镑。 英国药品和健康产品管理局（MHRA）主席、牛津大学基层医疗教授安东尼·哈恩登（Anthony Harnden）教授表示： “去年的论文竞赛表明，医学生和基础培训医生对提高药物安全性的挑战有着高度的参与热情。人工智能在医疗保健中的应用这一主题恰逢其时。随着这些技术成为日常临床实践的一部分，我们需要下一代医疗保健专业人员现在就思考如何识别和报告它们所带来的风险。今年我们将竞赛范围扩大到了药学专业学生，以认可他们在药物安全中发挥的重要作用。我鼓励每一位符合条件的学生参与其中，无论是学医还是学药；你们的见解能够真正帮助塑造我们在全国范围内监测人工智能医疗器械安全的方式。” 行动呼吁——报告所有医疗保健产品的安全问题 药品、疫苗、血液制品和医疗器械能够挽救生命、改善健康，但也可能出现问题。副作用可能突然出现或逐渐发展，而器械问题可能涉及缺陷、故障或意外结果。 在提交黄卡报告之前，您无需证明某个产品导致了该问题。当反应严重、影响日常生活、未在产品或用户信息中列出，或在药物、剂量或联合治疗方案发生改变后出现时，报告尤为重要。 MHRA首席安全官Alison Cave表示： “每一份黄卡报告都至关重要。它为我们提供了关于药品和医疗器械实际使用情况的真实世界证据，并帮助我们识别此前可能未被发现的安全问题。 如果您怀疑出现副作用、遇到医疗器械问题、发现药品可能存在缺陷，或认为某个医疗产品可能是假药，请不要忽视。您无需确定，您的报告可以帮助我们串联线索，保护他人免受伤害。 “我尤其鼓励医疗专业人员报告医疗器械（包括人工智能赋能的器械）相关问题，因为我们知道目前这类报告率较低。随着这些技术在临床实践中日益普及，这类第一手报告对于帮助我们及早发现并应对安全问题至关重要。” 请为以下情况提交黄卡： 疑似由药品、疫苗、草药、顺势疗法产品或电子烟产品引起的副作用 医疗器械事件，包括故障、失效或意外行为 疑似缺陷药品或对产品质量的担忧 疑似假药或无证医疗产品，尤其是通过互联网或社交媒体获取的产品 任何人都可以报告，包括患者、父母、照护者和医疗专业人员。报告应包含尽可能多的信息，但即使并非所有细节都可获得，报告仍然有价值。 如何报告 在 yellowcard.mhra.gov.uk 在线报告，或通过 Yellow Card 应用程序报告。报告通常只需几分钟。如果您担心自己的健康，请联系医疗专业人员；Yellow Card 计划无法提供医疗建议。 参加2026年患者安全征文比赛。 保持知情并帮助传播信息 阅读产品随附的患者信息说明书或使用说明，与医疗专业人员讨论已知副作用，并考虑新出现或正在变化的症状是否可能与医疗产品有关。 不要忽视疑似副作用或其他安全问题——通过 Yellow Card 计划进行报告。 致编辑的说明 征文比赛的完整条款和条件可在以下网址获取：Patient safety essay competition #MedSafetyWeek 是由乌普萨拉监测中心（Uppsala Monitoring Centre）领导的国际活动，该中心是世界卫生组织国际药物监测合作中心。该活动得到世界卫生组织、国际药品监管机构联盟成员以及其他关注药物安全的国家和国际组织的支持。自 #MedSafetyWeek 启动以来，MHRA 一直是其规划团队的成员。 2026年活动于11月2日至8日举行。预计来自120多个国家的130多个组织将以60多种语言分享活动信息。 MHRA负责监管英国所有药品和医疗器械，确保其有效且安全可接受。MHRA是卫生与社会保障部的执行机构。 如果人们担心自己的健康，应联系医疗专业人员。MHRA无法提供个体化医疗建议。 媒体咨询请联系 newscentre@mhra.gov.uk 或致电 020 3080 7651。 分享此页面 以下链接将在新标签页中打开 分享到 Facebook （在新标签页中打开） 分享到 X （在新标签页中打开） 探索主题 医疗器械监管与安全 警戒、安全警报与指南 患者安全
正文 · 英文原文
Press release MHRA launches patient safety essay competition for MedSafetyWeek The MHRA reminds patients, parents, carers and healthcare professionals to report suspected side effects through the Yellow Card scheme for MedSafetyWeek 2026. From: Medicines and Healthcare products Regulatory Agency Published: 2 November 2026 Graphic for #MedSafety Week The Medicines and Healthcare products Regulatory Agency (MHRA) is urging everyone to help protect patients by reporting all types of safety concerns from medicines and healthcare products, including medical devices, using the Yellow Card scheme, as part of the eleventh annual #MedSafetyWeek (2-8 November 2026) campaign. This year’s global campaign message is clear: “Don’t ignore suspected side effects, report them.” More than 130 organisations from over 120 countries will share medicines-safety messages in more than 60 languages. You can support the campaign to raise awareness of the Yellow Card scheme by using the new campaign materials on the Yellow Card website, including posters, digital screens, waiting room materials and social media assets, to raise awareness and promote Yellow Card reporting and by following MHRA social media channels and sharing content using #MHRAYellowCard, #MedSafetyWeek, #ReportSideEffects and #patientsafety to raise awareness of reporting. To coincide with #MedSafetyWeek, the MHRA has also launched its 2026 national patient safety essay competition on the detection and reporting of AI-related adverse events. This year the competition also invites pharmacy students to take place alongside UK medical students. Essay competition widens to pharmacy students following strong demand The MHRA Patient Safety Essay Competition launched last year to a strong response, with 68 entries received from more than 30 medical schools across the UK. Following queries from pharmacists keen to get involved, the MHRA has expanded the 2026 competition to include pharmacy students, reflecting the vital role pharmacy professionals play in medicine safety. Entrants are invited to submit an essay of up to 2,000 words on the topic: “Artificial intelligence (AI) is expected to play a transformative role in healthcare over the next 5 years. Using examples, explain how the Yellow Card scheme can enable the identification of risks associated with the adoption of AI as a medical device. Consider practical ways to improve the detection and reporting of AI-related adverse events by patients and healthcare professionals using the Yellow Card scheme. Discuss how improved reporting could support the safe use of AI-enabled medical devices.” Entries close on Monday 11 January 2027. Six prizes are available. First prize winners receive £500 and an invitation to present their essay at a national meeting of the Commission on Human Medicines (CHM), the independent advisory body on medicine safety, and the Interim Devices Working Group (IDWG). Second and third prizes of £300 and £200 are also available in each category. Professor Anthony Harnden, MHRA Chair and professor of primary care at the University of Oxford, said: “Last year’s essay competition showed just how engaged medical students and foundation doctors are with the challenge of making medicines safer. The theme of AI in healthcare could not be more timely. As these technologies become part of everyday clinical practice, we need the next generation of healthcare professionals thinking now about how we identify and report the risks they bring. This year we’ve widened the competition to pharmacy students too, recognising the vital role they play in medicine safety. I’d encourage every eligible student to take part, whether studying medicine or pharmacy; your insight could genuinely help shape how we monitor the safety of AI-enabled medical devices across the country.” A call to action – report safety concerns from all healthcare products Medicines, vaccines, blood products and medical devices save lives and improve health, but problems can occur. Side effects may appear suddenly or develop gradually, while device problems may involve faults, failures or unexpected results. You do not need to prove that a product caused the problem before submitting a Yellow Card. Reports are particularly important when a reaction is serious, affects day-to-day life, is not listed in the product or user information, or follows a change in medicine, dose or combination of treatments. Alison Cave, Chief Safety Officer at the MHRA, said: “Every Yellow Card report matters. It gives us real-world evidence about how medicines and medical devices are being used and helps us identify possible safety issues that may not have been seen before. If you suspect a side effect, experience a problem with a medical device, find a medicine may be defective, or think a medical product could be fake, please do not ignore it. You do not need to be certain, and your report could help us connect the dots and protect others from harm. “I’d particularly encourage healthcare professionals to report problems with medical devices, including AI-enabled devices, where we know reporting rates are currently low. As these technologies become more common in clinical practice, this kind of first-hand reporting is vital to help us spot and act on safety issues early. “ Please submit a Yellow Card for: Suspected side effects from medicines, vaccines, herbal remedies, homeopathic products or e-cigarette products Medical device incidents, including faults, failures or unexpected behaviour Suspected defective medicines or concerns about product quality Suspected fake or unlicensed medical products, particularly those obtained online or through social media Anyone can report, including patients, parents, carers and healthcare professionals. A report should include as much information as possible, but it is still valuable if every detail is not available. How to report Report online at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting usually takes only a few minutes. If you are worried about your health, contact a healthcare professional; the Yellow Card scheme cannot provide medical advice. Enter the 2026 essay competition at Patient safety essay competition. Stay informed and help spread the message Read the patient information leaflet or instructions supplied with a product, discuss known side effects with a healthcare professional, and consider whether new or changing symptoms could be linked to the healthcare product. Don’t ignore suspected side effects or other safety concerns – report them through the Yellow Card scheme. Notes to Editors The full terms and conditions for the essay competition are available at: Patient safety essay competition #MedSafetyWeek is an international campaign led by Uppsala Monitoring Centre, the World Health Organization Collaborating Centre for International Drug Monitoring. The campaign is supported by the World Health Organization, members of the International Coalition of Medicines Regulatory Authorities and other national and international organisations with an interest in medicine safety. MHRA is part of the planning team for #MedSafetyWeek since its inception. The 2026 campaign runs from 2-8 November. More than 130 organisations from over 120 countries are expected to share campaign messages in more than 60 languages. The MHRA is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. The MHRA is an executive agency of the Department of Health and Social Care. People should contact a healthcare professional if they are worried about their health. The MHRA cannot provide individual medical advice. For media enquiries, contact newscentre@mhra.gov.uk or call 020 3080 7651. Share this page The following links open in a new tab Share on Facebook (opens in new tab) Share on X (opens in new tab) Explore the topic Medical devices regulation and safety Vigilance, safety alerts and guidance Patient safety